ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Contraceptive Injectable Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-32T14373
Home | Market Reports | Health| Reproductive Health
Global Contraceptive Injectable Market Research Report 2023
BUY CHAPTERS

Global Contraceptive Injectable Market Research Report 2025

Code: QYRE-Auto-32T14373
Report
May 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Church Dwight
Pfizer Inc
Afaxys
Agile Therapeutics
Janssen Pharmaceuticals, Inc.
Veru Inc.
China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
Organon Group Of Companies

Contraceptive Injectable Market

The global market for Contraceptive Injectable was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Contraceptive Injectable is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Contraceptive Injectable is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Contraceptive Injectable include Bayer AG, China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Church & Dwight, Organon Group Of Companies, Pfizer Inc., Afaxys, Inc., Agile Therapeutics, Janssen Pharmaceuticals, Inc., Veru, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Contraceptive Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptive Injectable.
The Contraceptive Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Contraceptive Injectable market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contraceptive Injectable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Contraceptive Injectable Market Report

Report Metric Details
Report Name Contraceptive Injectable Market
Segment by Type
  • Long-Acting Contraception
  • Short-Acting Contraception
Segment by Application
  • Male
  • Female
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer AG, China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Church & Dwight, Organon Group Of Companies, Pfizer Inc., Afaxys, Inc., Agile Therapeutics, Janssen Pharmaceuticals, Inc., Veru, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Contraceptive Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Contraceptive Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Contraceptive Injectable Market report?

Ans: The main players in the Contraceptive Injectable Market are Bayer AG, China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Church & Dwight, Organon Group Of Companies, Pfizer Inc., Afaxys, Inc., Agile Therapeutics, Janssen Pharmaceuticals, Inc., Veru, Inc.

What are the Application segmentation covered in the Contraceptive Injectable Market report?

Ans: The Applications covered in the Contraceptive Injectable Market report are Male, Female

What are the Type segmentation covered in the Contraceptive Injectable Market report?

Ans: The Types covered in the Contraceptive Injectable Market report are Long-Acting Contraception, Short-Acting Contraception

1 Contraceptive Injectable Market Overview
1.1 Product Definition
1.2 Contraceptive Injectable by Type
1.2.1 Global Contraceptive Injectable Market Value Comparison by Type (2024 VS 2031)
1.2.2 Long-Acting Contraception
1.2.3 Short-Acting Contraception
1.3 Contraceptive Injectable by Application
1.3.1 Global Contraceptive Injectable Market Value by Application (2024 VS 2031)
1.3.2 Male
1.3.3 Female
1.4 Global Contraceptive Injectable Market Size Estimates and Forecasts
1.4.1 Global Contraceptive Injectable Revenue 2020-2031
1.4.2 Global Contraceptive Injectable Sales 2020-2031
1.4.3 Global Contraceptive Injectable Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Contraceptive Injectable Market Competition by Manufacturers
2.1 Global Contraceptive Injectable Sales Market Share by Manufacturers (2020-2025)
2.2 Global Contraceptive Injectable Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Contraceptive Injectable Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Contraceptive Injectable, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Contraceptive Injectable, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Contraceptive Injectable, Product Type & Application
2.7 Global Key Manufacturers of Contraceptive Injectable, Date of Enter into This Industry
2.8 Global Contraceptive Injectable Market Competitive Situation and Trends
2.8.1 Global Contraceptive Injectable Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Contraceptive Injectable Players Market Share by Revenue
2.8.3 Global Contraceptive Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Contraceptive Injectable Market Scenario by Region
3.1 Global Contraceptive Injectable Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Contraceptive Injectable Sales by Region: 2020-2031
3.2.1 Global Contraceptive Injectable Sales by Region: 2020-2025
3.2.2 Global Contraceptive Injectable Sales by Region: 2026-2031
3.3 Global Contraceptive Injectable Revenue by Region: 2020-2031
3.3.1 Global Contraceptive Injectable Revenue by Region: 2020-2025
3.3.2 Global Contraceptive Injectable Revenue by Region: 2026-2031
3.4 North America Contraceptive Injectable Market Facts & Figures by Country
3.4.1 North America Contraceptive Injectable Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Contraceptive Injectable Sales by Country (2020-2031)
3.4.3 North America Contraceptive Injectable Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Contraceptive Injectable Market Facts & Figures by Country
3.5.1 Europe Contraceptive Injectable Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Contraceptive Injectable Sales by Country (2020-2031)
3.5.3 Europe Contraceptive Injectable Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contraceptive Injectable Market Facts & Figures by Region
3.6.1 Asia Pacific Contraceptive Injectable Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Contraceptive Injectable Sales by Region (2020-2031)
3.6.3 Asia Pacific Contraceptive Injectable Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Contraceptive Injectable Market Facts & Figures by Country
3.7.1 Latin America Contraceptive Injectable Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Contraceptive Injectable Sales by Country (2020-2031)
3.7.3 Latin America Contraceptive Injectable Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contraceptive Injectable Market Facts & Figures by Country
3.8.1 Middle East and Africa Contraceptive Injectable Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Contraceptive Injectable Sales by Country (2020-2031)
3.8.3 Middle East and Africa Contraceptive Injectable Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Contraceptive Injectable Sales by Type (2020-2031)
4.1.1 Global Contraceptive Injectable Sales by Type (2020-2025)
4.1.2 Global Contraceptive Injectable Sales by Type (2026-2031)
4.1.3 Global Contraceptive Injectable Sales Market Share by Type (2020-2031)
4.2 Global Contraceptive Injectable Revenue by Type (2020-2031)
4.2.1 Global Contraceptive Injectable Revenue by Type (2020-2025)
4.2.2 Global Contraceptive Injectable Revenue by Type (2026-2031)
4.2.3 Global Contraceptive Injectable Revenue Market Share by Type (2020-2031)
4.3 Global Contraceptive Injectable Price by Type (2020-2031)
5 Segment by Application
5.1 Global Contraceptive Injectable Sales by Application (2020-2031)
5.1.1 Global Contraceptive Injectable Sales by Application (2020-2025)
5.1.2 Global Contraceptive Injectable Sales by Application (2026-2031)
5.1.3 Global Contraceptive Injectable Sales Market Share by Application (2020-2031)
5.2 Global Contraceptive Injectable Revenue by Application (2020-2031)
5.2.1 Global Contraceptive Injectable Revenue by Application (2020-2025)
5.2.2 Global Contraceptive Injectable Revenue by Application (2026-2031)
5.2.3 Global Contraceptive Injectable Revenue Market Share by Application (2020-2031)
5.3 Global Contraceptive Injectable Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Company Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Contraceptive Injectable Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer AG Contraceptive Injectable Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
6.2.1 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information
6.2.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Description and Business Overview
6.2.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales, Revenue and Gross Margin (2020-2025)
6.2.4 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio
6.2.5 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Developments/Updates
6.3 Church & Dwight
6.3.1 Church & Dwight Company Information
6.3.2 Church & Dwight Description and Business Overview
6.3.3 Church & Dwight Contraceptive Injectable Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Church & Dwight Contraceptive Injectable Product Portfolio
6.3.5 Church & Dwight Recent Developments/Updates
6.4 Organon Group Of Companies
6.4.1 Organon Group Of Companies Company Information
6.4.2 Organon Group Of Companies Description and Business Overview
6.4.3 Organon Group Of Companies Contraceptive Injectable Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Organon Group Of Companies Contraceptive Injectable Product Portfolio
6.4.5 Organon Group Of Companies Recent Developments/Updates
6.5 Pfizer Inc.
6.5.1 Pfizer Inc. Company Information
6.5.2 Pfizer Inc. Description and Business Overview
6.5.3 Pfizer Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Inc. Contraceptive Injectable Product Portfolio
6.5.5 Pfizer Inc. Recent Developments/Updates
6.6 Afaxys, Inc.
6.6.1 Afaxys, Inc. Company Information
6.6.2 Afaxys, Inc. Description and Business Overview
6.6.3 Afaxys, Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Afaxys, Inc. Contraceptive Injectable Product Portfolio
6.6.5 Afaxys, Inc. Recent Developments/Updates
6.7 Agile Therapeutics
6.7.1 Agile Therapeutics Company Information
6.7.2 Agile Therapeutics Description and Business Overview
6.7.3 Agile Therapeutics Contraceptive Injectable Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Agile Therapeutics Contraceptive Injectable Product Portfolio
6.7.5 Agile Therapeutics Recent Developments/Updates
6.8 Janssen Pharmaceuticals, Inc.
6.8.1 Janssen Pharmaceuticals, Inc. Company Information
6.8.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
6.8.3 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio
6.8.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
6.9 Veru, Inc.
6.9.1 Veru, Inc. Company Information
6.9.2 Veru, Inc. Description and Business Overview
6.9.3 Veru, Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Veru, Inc. Contraceptive Injectable Product Portfolio
6.9.5 Veru, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contraceptive Injectable Industry Chain Analysis
7.2 Contraceptive Injectable Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contraceptive Injectable Production Mode & Process Analysis
7.4 Contraceptive Injectable Sales and Marketing
7.4.1 Contraceptive Injectable Sales Channels
7.4.2 Contraceptive Injectable Distributors
7.5 Contraceptive Injectable Customer Analysis
8 Contraceptive Injectable Market Dynamics
8.1 Contraceptive Injectable Industry Trends
8.2 Contraceptive Injectable Market Drivers
8.3 Contraceptive Injectable Market Challenges
8.4 Contraceptive Injectable Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Church Dwight
Pfizer Inc
Afaxys
Agile Therapeutics
Janssen Pharmaceuticals, Inc.
Veru Inc.
China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
Organon Group Of Companies
List of Tables
 Table 1. Global Contraceptive Injectable Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Contraceptive Injectable Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Contraceptive Injectable Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Contraceptive Injectable Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Contraceptive Injectable Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Contraceptive Injectable Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Contraceptive Injectable Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Contraceptive Injectable Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Contraceptive Injectable, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Contraceptive Injectable, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Contraceptive Injectable, Product Type & Application
 Table 12. Global Key Manufacturers of Contraceptive Injectable, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Contraceptive Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive Injectable as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Contraceptive Injectable Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Contraceptive Injectable Sales by Region (2020-2025) & (K Units)
 Table 18. Global Contraceptive Injectable Sales Market Share by Region (2020-2025)
 Table 19. Global Contraceptive Injectable Sales by Region (2026-2031) & (K Units)
 Table 20. Global Contraceptive Injectable Sales Market Share by Region (2026-2031)
 Table 21. Global Contraceptive Injectable Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Contraceptive Injectable Revenue Market Share by Region (2020-2025)
 Table 23. Global Contraceptive Injectable Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Contraceptive Injectable Revenue Market Share by Region (2026-2031)
 Table 25. North America Contraceptive Injectable Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Contraceptive Injectable Sales by Country (2020-2025) & (K Units)
 Table 27. North America Contraceptive Injectable Sales by Country (2026-2031) & (K Units)
 Table 28. North America Contraceptive Injectable Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Contraceptive Injectable Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Contraceptive Injectable Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Contraceptive Injectable Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Contraceptive Injectable Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Contraceptive Injectable Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Contraceptive Injectable Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Contraceptive Injectable Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Contraceptive Injectable Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Contraceptive Injectable Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Contraceptive Injectable Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Contraceptive Injectable Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Contraceptive Injectable Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Contraceptive Injectable Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Contraceptive Injectable Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Contraceptive Injectable Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Contraceptive Injectable Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Contraceptive Injectable Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Contraceptive Injectable Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Contraceptive Injectable Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Contraceptive Injectable Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Contraceptive Injectable Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Contraceptive Injectable Sales (K Units) by Type (2020-2025)
 Table 51. Global Contraceptive Injectable Sales (K Units) by Type (2026-2031)
 Table 52. Global Contraceptive Injectable Sales Market Share by Type (2020-2025)
 Table 53. Global Contraceptive Injectable Sales Market Share by Type (2026-2031)
 Table 54. Global Contraceptive Injectable Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Contraceptive Injectable Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Contraceptive Injectable Revenue Market Share by Type (2020-2025)
 Table 57. Global Contraceptive Injectable Revenue Market Share by Type (2026-2031)
 Table 58. Global Contraceptive Injectable Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Contraceptive Injectable Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Contraceptive Injectable Sales (K Units) by Application (2020-2025)
 Table 61. Global Contraceptive Injectable Sales (K Units) by Application (2026-2031)
 Table 62. Global Contraceptive Injectable Sales Market Share by Application (2020-2025)
 Table 63. Global Contraceptive Injectable Sales Market Share by Application (2026-2031)
 Table 64. Global Contraceptive Injectable Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Contraceptive Injectable Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Contraceptive Injectable Revenue Market Share by Application (2020-2025)
 Table 67. Global Contraceptive Injectable Revenue Market Share by Application (2026-2031)
 Table 68. Global Contraceptive Injectable Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Contraceptive Injectable Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer AG Company Information
 Table 71. Bayer AG Description and Business Overview
 Table 72. Bayer AG Contraceptive Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer AG Contraceptive Injectable Product
 Table 74. Bayer AG Recent Developments/Updates
 Table 75. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information
 Table 76. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Description and Business Overview
 Table 77. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product
 Table 79. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Developments/Updates
 Table 80. Church & Dwight Company Information
 Table 81. Church & Dwight Description and Business Overview
 Table 82. Church & Dwight Contraceptive Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Church & Dwight Contraceptive Injectable Product
 Table 84. Church & Dwight Recent Developments/Updates
 Table 85. Organon Group Of Companies Company Information
 Table 86. Organon Group Of Companies Description and Business Overview
 Table 87. Organon Group Of Companies Contraceptive Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Organon Group Of Companies Contraceptive Injectable Product
 Table 89. Organon Group Of Companies Recent Developments/Updates
 Table 90. Pfizer Inc. Company Information
 Table 91. Pfizer Inc. Description and Business Overview
 Table 92. Pfizer Inc. Contraceptive Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Inc. Contraceptive Injectable Product
 Table 94. Pfizer Inc. Recent Developments/Updates
 Table 95. Afaxys, Inc. Company Information
 Table 96. Afaxys, Inc. Description and Business Overview
 Table 97. Afaxys, Inc. Contraceptive Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Afaxys, Inc. Contraceptive Injectable Product
 Table 99. Afaxys, Inc. Recent Developments/Updates
 Table 100. Agile Therapeutics Company Information
 Table 101. Agile Therapeutics Description and Business Overview
 Table 102. Agile Therapeutics Contraceptive Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Agile Therapeutics Contraceptive Injectable Product
 Table 104. Agile Therapeutics Recent Developments/Updates
 Table 105. Janssen Pharmaceuticals, Inc. Company Information
 Table 106. Janssen Pharmaceuticals, Inc. Description and Business Overview
 Table 107. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product
 Table 109. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
 Table 110. Veru, Inc. Company Information
 Table 111. Veru, Inc. Description and Business Overview
 Table 112. Veru, Inc. Contraceptive Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Veru, Inc. Contraceptive Injectable Product
 Table 114. Veru, Inc. Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Contraceptive Injectable Distributors List
 Table 118. Contraceptive Injectable Customers List
 Table 119. Contraceptive Injectable Market Trends
 Table 120. Contraceptive Injectable Market Drivers
 Table 121. Contraceptive Injectable Market Challenges
 Table 122. Contraceptive Injectable Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Contraceptive Injectable
 Figure 2. Global Contraceptive Injectable Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Contraceptive Injectable Market Share by Type: 2024 & 2031
 Figure 4. Long-Acting Contraception Product Picture
 Figure 5. Short-Acting Contraception Product Picture
 Figure 6. Global Contraceptive Injectable Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Contraceptive Injectable Market Share by Application: 2024 & 2031
 Figure 8. Male
 Figure 9. Female
 Figure 10. Global Contraceptive Injectable Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Contraceptive Injectable Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Contraceptive Injectable Sales (2020-2031) & (K Units)
 Figure 13. Global Contraceptive Injectable Average Price (US$/Unit) & (2020-2031)
 Figure 14. Contraceptive Injectable Report Years Considered
 Figure 15. Contraceptive Injectable Sales Share by Manufacturers in 2024
 Figure 16. Global Contraceptive Injectable Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Contraceptive Injectable Players: Market Share by Revenue in Contraceptive Injectable in 2024
 Figure 18. Contraceptive Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Contraceptive Injectable Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Contraceptive Injectable Sales Market Share by Country (2020-2031)
 Figure 21. North America Contraceptive Injectable Revenue Market Share by Country (2020-2031)
 Figure 22. United States Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Contraceptive Injectable Sales Market Share by Country (2020-2031)
 Figure 25. Europe Contraceptive Injectable Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Contraceptive Injectable Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Contraceptive Injectable Revenue Market Share by Region (2020-2031)
 Figure 33. China Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Contraceptive Injectable Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Contraceptive Injectable Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Contraceptive Injectable Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Contraceptive Injectable Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Contraceptive Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Contraceptive Injectable by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Contraceptive Injectable by Type (2020-2031)
 Figure 52. Global Contraceptive Injectable Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Contraceptive Injectable by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Contraceptive Injectable by Application (2020-2031)
 Figure 55. Global Contraceptive Injectable Price (US$/Unit) by Application (2020-2031)
 Figure 56. Contraceptive Injectable Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Long acting Contraceptive Injection Market Research Report 2024
Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Short Acting Contraceptives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hormonal Contraceptive Implant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Female Contraception Market Research Report 2024
Contraceptive Pills Market
Injectable Pain Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Birth Control Rings Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microparticle Injectables Market Research Report 2024
Injection and Infusion Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Syringe Microinjection Pump Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injectable Moisturiser Market Research Report 2025
Medical Implantable Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Molecule Injectable Market Research Report 2024
Hormonal Intrauterine Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Female Oral Contraceptives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fulvestrant Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Implanted Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Female Contraceptive Pill Market Insights Forecast to 2030

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions